RITE AID

The testing site opened Monday following Rite Aid's joining of the White House COVID-19 Response Working Group.

Rite Aid CEO outlined the steps the retailer it taking to foment its "RxEvolution" in an exclusive interview with Drug Store News.

Rite Aid is taking new steps to support customers, employees and communities in light of the COVID-19 outbreak.

As the COVID-19 pandemic continues, the industry is taking steps to keep stores safe for consumers and associates while still serving as a resource. 

Rite Aid's analyst day highlighted the company's new strategic direction and plans to focus on its PBM, leveraging its pharmacists to improve patient health and building a store that appeals to younger shoppers.

DSN managing editor David Salazar discusses how Rite Aid is standing by its customers by standing by associates, and how the industry can lead in that area.

Andre Persaud, who has roughly 25 years of experience in various types of retailing, has been named Rite Aid's executive vice president of retail operations.

Rite Aid posted earnings of $52.3 million, compared with a $17.3 million net loss in the prior year’s third quarter, which CEO Heyward Donigan said offers momentum as the company plans to unveil a long-term growth strategy.

The company has named Dan Robson president of EnvisionRxOptions from his role as president of MedTrakRx, one of the PBM's subsidiary.

The Camp Hill, Pa.-based retailer has named a new COO, with Bryan Everett stepping down to pursue other opportunities.

The Rite Aid Foundation is marking “Giving Tuesday” by awarding more than $2 million to partner charities through its Full of Thanks Holiday Program.

Rite Aid reported a net loss of $78.7 million, or $1.48 per share, and adjusted net income of $6.3 million, or 12 cents per share.